The speaker list for Orphan Drugs Summit 2014 consists of experts and executives from the world of orphan drugs. The list of speakers will be revealed here shortly.

If you would like to participate as a keynote presenter, panelist, or roundtable moderator, please contact the Content Director with your contact details and topic of interest at:

Amo Mostofi, Editorial Content Director
Contact: amo.mostofi (at) copperberg.com


Download the agenda here: >> Orphan Drugs Summit 2014.pdf


Useful content, many new ideas and topics to follow-up 
- Global Project Leader, GHEOR Global Market Access, Bayer HealthCare

A great event, created by the high quality of the speakers, the right amount of interactivity and the heterogeneity of the participants!
Buisness Development Manager Europe, Hospira One 2 One

Great coverage of Orphan Drug issues and opportunities
- CEO, TikoMed


Mark my calendar for Pricing Conference

Become a partner for Pricing Conference

Register Now for Pricing Conference

Join our community for Pricing Conference

A note from the editor

On behalf of the entire Copperberg team, welcome to the annual Orphan Drugs Summit!

In 2013 Copenhagen hosted the Orphan Drugs Summit for the third time and offered over 150 delegates the unique opportunity to meet and interact with all major orphan drugs stakeholders.

Once again Orphan Drugs Summit proved it is the leading rare disease event in Northern Europe. A well-established platform where pharmaceutical companies of all sizes, hospital representatives, researchers, patient organizations, venture capitalists, regulatory bodies, and industry associations meet to discuss and influence the future of orphan drugs.

The Summit is designed to increase interaction among participants, promote knowledge flow and instigate partnerships and alliances for those working with orphan drugs.

Once again we have further increased networking opportunities and invited leading industry professionals with gripping presentations to address the following topics:
  • Market Access challenges and strategies
  • Incentives & regulatory framework
  • Patient registries
  • Access to Orphan Drugs
  • Partnerships and Financing
  • Pricing & Reimbursement
  • Scientific & Clinical Development
Welcome on board and I hope you will enjoy the 4th annual Orphan Drugs Summit in Copenhagen on 17-19 September 2014.


Amo Mostofi